Celyad and Institut Curie in NKR-T collaboration
22 March 2016 | By Victoria White
Celyad is teaming up with the Inserm Unit of Institut Curie in Paris, France, to further develop its NKR-T pipeline in cellular immunotherapies for cancer...
List view / Grid view
News
Researchers identify the ‘Achilles heel’ of bacteria
21 March 2016 | By Victoria White
The discovery, a crucial step in bacteria's energy metabolism, may be the first step in developing an entirely novel form of antibiotics...
Ethris publishes mRNA therapy musculoskeletal regeneration data
21 March 2016 | By Victoria White
Ethris has announced the publication of data that underlines the broad therapeutic potential of the company’s proprietary mRNA transcript therapy platform...
Scientists develop technique for viewing cells and tissues in 3D under the skin
21 March 2016 | By Victoria White
The MOZART technique could allow scientists to detect tumours in the skin or see abnormal blood vessels from the early stages of macular degeneration...
Researchers identify ABHD2 as compound needed for sperm activation
21 March 2016 | By Victoria White
The finding may lead to new options for male contraception as well as treatments for infertility resulting from problems with sperm mobility...
Implant turns the immune system against Alzheimer’s disease
17 March 2016 | By Victoria White
Scientists have developed a capsule containing cells that have been genetically engineered to produce antibodies against the Abeta...
IPROVE launches roadmap to bolster vaccine innovation
17 March 2016 | By Victoria White
IPROVE has launched a strategy setting out a vision for vaccine research and innovation in Europe over the next 20 years...
Cellectis and MabQuest to develop new class of anti-PD-1 mAbs
17 March 2016 | By Victoria White
These anti-PD-1 mAbs have potential uses for multiple indications in immunotherapy, including notably treatments for a variety of cancers...
Interview with Michael Springer, Associate Professor of Systems Biology, Harvard Medical School
17 March 2016 | By Caroline Richards
Caroline Richards, Editor of Drug Target Review, invites Michael Springer, Associate Professor of Systems Biology, Harvard Medical School to discuss a laboratory study of a yeast model using microfluidic systems...
Amping antimicrobial discovery with high-throughput screening
16 March 2016 | By Victoria White
Researchers from NIST have shown that high-throughput screening can dramatically speed up the challenging task of antimicrobial discovery...
Inovio and Wistar team up for DNA-based immunotherapies
16 March 2016 | By Victoria White
Inovio and the Wistar Institute are to research preventive and therapeutic DNA-based immunotherapies for cancers and infectious diseases...
Sanofi and DiCE Molecules enter research collaboration
16 March 2016 | By Victoria White
Sanofi and DiCE Molecules have entered a five-year global collaboration to discover potential new therapeutics for up to 12 targets...
Johnson & Johnson Innovation launches JLINX
16 March 2016 | By Victoria White
JLINX is designed to catalyse scientific innovations by offering start-ups flexible ways to grow and collaborate across the European life science ecosystem...
SRI International awarded $19.8m to develop cancer preventive vaccines
15 March 2016 | By Victoria White
A division of SRI International will conduct preclinical studies to assess the efficacy of compounds or vaccines for preventing invasive-cancer development...
Blueprint Medicines to develop novel therapeutics targeting immunokinases
15 March 2016 | By Victoria White
Under a collaboration with Roche, Blueprint Medicines will lead preclinical research and development through to Phase I proof of concept...
